prof. Vanessa Smith

The TFIID complex is a new autoantibody target in systemic sclerosis

Jean-Baptiste Vulsteke, Birthe Michiels, Vanessa Smith (UGent) , Yves Piette (UGent) , Marie Vanthuyne, Carole Lacout, Antoine Brochard, Mohammed Tikly, Jonas De Leeuw, Doreen Dillaerts, et al.

(2026) ANNALS OF THE RHEUMATIC DISEASES. 85(2). p.393-395

Add to list

Work participation and work disability in Belgian patients with systemic sclerosis

Ine Desimpele (UGent) , Ann-Sophie De Craemer (UGent) , Saskia Decuman, Annick Viaene (UGent) , Piet Mortele, Lauren Delmez (UGent) , Philippe Carron (UGent) , Dirk Elewaut (UGent) , Filip Van den Bosch (UGent) and Vanessa Smith (UGent)

(2026) RHEUMATOLOGY. 65(1).

Add to list

Journal Article
A1
open access

Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers : in vitro and ex vivo study

Vanessa Smith (UGent) , Stefano Soldano, Rosanna Campitiello, Paola Montagna, Andrea Cere (UGent) , Elvis Hysa, Tamara Vojinovic, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, et al.

(2025) RMD OPEN. 11(4).

Add to list

Detection of anti-RuvBL1/2 autoantibodies by targeted liquid chromatography–tandem mass spectrometry

Tom Dehaemers, Birthe Michiels, Rita Derua, Yves Piette (UGent) , Carolien Bonroy (UGent) , Jonas De Leeuw, Doreen Dillaerts, Nele Peersman, Maaike Cockx, Tom De Waal, et al.

(2025) JOURNAL OF APPLIED LABORATORY MEDICINE. 10(4). p.820-832

Add to list

Tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio and cardiorenal syndrome type 2 in the systemic sclerosis EUSTAR cohort

Amalia Colalillo, Chiara Pellicano, Lidia P. Ananyeva, Eric Hachulla, Giovanna Cuomo, Andrea‐Hermina Györfi, László Czirják, Jeska de Vries‐Bouwstra, Luc Mouthon, Hadi Poormoghim, et al.

(2025) ARTHRITIS CARE & RESEARCH. 77(2). p.257-265

Add to list

Journal Article
A1
open access

Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease

Stefano Soldano, Vanessa Smith (UGent) , Paola Montagna, Emanuele Gotelli, Rosanna Campitiello, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, Andrea Cere (UGent) and Maurizio Cutolo

(2024) ARTHRITIS RESEARCH & THERAPY. 26(1).

Add to list

Journal Article
A1
open access

Flemish network on rare connective tissue diseases (CTD) : patient pathways in systemic sclerosis : first steps taken

Yves Piette (UGent) , Freek Van den Bossche (UGent) , J. Aerts, N. Aerts, S. Ajeganova, V. Badot, N. Berghen, D. Blockmans, Guy Brusselle (UGent) , N. Caeyers, et al.

(2024) ACTA CLINICA BELGICA. 79(1). p.26-33

Add to list

Journal Article
A1
open access

Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

Yannick Allanore, Dinesh Khanna, Vanessa Smith (UGent) , Martin Aringer, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Peter A Merkel, Christian Stock, Steven Sambevski, Christopher P Denton, et al.

(2024) RHEUMATOLOGY. 63(3). p.639-647

Add to list

Journal Article
A1
open access

Does the impact of COVID‐19 on patients with systemic sclerosis change over time?

Elisabeth Deibel, Patricia E. Carreira, Madelon Vonk, Nicoletta del Papa, Radim Bečvář, Alfredo Guillén‐Del‐Castillo, Corrado Campochiaro, Hadi Poormoghim, Sophie Liem, Maria‐Grazia Lazzaroni, et al.

(2024) ARTHRITIS CARE & RESEARCH. 76(1). p.88-97

Add to list

Microvascular and cutaneous assessment in adult patients with hypermobile Ehlers-Danlos syndrome

Alberto Sulli, Francesca Lalli, Elvis Hysa, Andrea Cere, Alessandro Pinelli, Silvia Sammori, Emanuele Gotelli, Carmen Pizzorni, Marco Castori, Fransiska Malfait (UGent) , et al.

(2023) ARTHRITIS & RHEUMATOLOGY. In Arthritis & Rheumatology 75(Supplement 9). p.494-495

Academic Bibliography

prof. Vanessa Smith

The TFIID complex is a new autoantibody target in systemic sclerosis

Work participation and work disability in Belgian patients with systemic sclerosis

Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers : in vitro and ex vivo study

Detection of anti-RuvBL1/2 autoantibodies by targeted liquid chromatography–tandem mass spectrometry

Tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio and cardiorenal syndrome type 2 in the systemic sclerosis EUSTAR cohort

Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease

Flemish network on rare connective tissue diseases (CTD) : patient pathways in systemic sclerosis : first steps taken

Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

Does the impact of COVID‐19 on patients with systemic sclerosis change over time?

Microvascular and cutaneous assessment in adult patients with hypermobile Ehlers-Danlos syndrome

Contents

Support

Contact